m+Medelevator.RU
← Поиск публикаций
Frontiers in cellular and infection microbiology · 2025

NGS-based approach for diagnostically unidentified Mycobacterium saskatchewanense, a rare non-tuberculous mycobacterium.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gatti Giulia, Ingletto Ludovica, Dirani Giorgio, Zannoli Silvia, Taddei Francesca, Colosimo Claudia, Dionisi Laura, Marzucco Anna, Montanari Maria Sofia, Denicolò Agnese, Congestrì Francesco, Grumiro Laura, Brandolini Martina, Guerra Massimiliano, De Pascali Alessandra Mistral, Scagliarini Alessandra, Cricca Monica, Sambri Vittorio

Аннотация

INTRODUCTION: The implementation of advanced technologies and algorithms for diagnosis and genome analysis has made a fundamental contribution to pathogens' identification and investigation.

METHODS: The study of non-tuberculous mycobacteria (NTM) benefited from a next-generation sequencing (NGS) approach, making it possible to describe sequences of rare pathogens. This study identified 20 diagnostically unknown isolates as Mycobacterium saskatchewanense ST 691, an environmental NTM. The isolates were sequenced on two different platforms to compare their throughput and to investigate shared and unique single nucleotide polymorphism (SNP) counts, phylogeny based on concatenated 16S, hsp65, and rpoB genes, and core-genome multilocus sequence typing (MLST), in order to broaden the current knowledge of Mycobacterium saskatchewanense.

RESULTS: Principal component analysis on the three genes combined with the mutations' annotation suggests that rpoB may serve as a suitable marker to distinguish M. saskatchewanense from other NTM.

DISCUSSION: Our results show that frontier studies performed using NGS can help in overcoming the limits of traditional diagnostic assays and deepen the knowledge on rare and uncommon NTM that are raising clinical concern.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты